Ralston biodiesel restart sees Chevron stock price extend its upward run

Traders Union
All News
Stocks
Chevron rises 1.45% to $216.37 today

Highlights

Chevron restarted its Ralston, Iowa biodiesel facility, increasing alternative fuel supply and improving its near-term performance outlook.
Vice Chairman Mark Nelson sold 112,000 Chevron shares at $210.48 each on November 10, 2026, signaling recent insider selling activity.
Chevron stock shows broad bullish technical momentum, with expected trading between $211.33 to $221.41 and signs of potential near-term consolidation.

Performance outlook improves as biodiesel plant restarts and insider sells

Chevron has restarted its biodiesel production facility in Ralston, Iowa, after a suspension earlier in 2024, a move that increases the local fuel supply and highlights the company's ongoing utilization of alternative energy assets, according to Gurufocus. This operational restart stands to improve near-term performance outlook and may foster a more favorable investor sentiment in the energy sector. Additionally, on November 10, 2026, Vice Chairman Mark Nelson completed a sale of 112,000 company shares at an average price of $210.48 per share, as reported by MarketBeat, a transaction that could introduce some caution regarding insider activity.

Bullish momentum sustained as price hovers above support and overbought signals emerge

On the hourly chart, CVX shows clear technical strength, trading above its MA-20 at $213.46 and MA-50 at $214.32, while maintaining a firm position above the long-term MA-200 at $195.55. Immediate intraday support is established at the Ichimoku Kijun level of $212.05, with the next key technical floor at $211.33. Momentum indicators reinforce the bullish setup: MACD flashes a buy, ADX implies buyers are in control, and Bull/Bear Power registers a strong positive reading of 2.4. Meanwhile, both RSI and Stoch RSI present neutral signals, while CCI is situated in the overbought zone, hinting at heightened risk for a short-term pullback but lacking confirmation for a reversal. The Awesome Oscillator further aligns with prevailing bullish momentum, though mixed signals from the overbought CCI suggest a measured approach.

Range-bound trade likely as breakout risk rises near key levels

Over the next few trading days, CVX is expected to fluctuate within the $211.33 to $221.41 range, reflecting typical volatility around current levels. The likelihood of an upward move is 50%, matched by an equal probability of a downturn. In the baseline scenario, the stock may trade sideways within this band; a decisive move above $221.41 could open the door to fresh highs, while a break below support at $211.33 would indicate a shift toward lower prices.

Anton Kharitonov, expert at Traders Union, sees Chevron’s recent biodiesel facility restart as a supportive event for the share price, but he remains cautious due to significant insider selling by company leadership. The technical picture is bullish in the short term, with price above major moving averages and momentum indicators positive, though overbought CCI suggests risk of a pullback. There is no clear directional bias as both upside and downside scenarios are equally probable in the current range. "Base case is consolidation between $211.33 and $221.41 — until one of these levels breaks, I remain on the sidelines."

Earlier, analysts noted that Chevron demonstrated fundamental stability and mixed technical signals as it navigated portfolio shifts including a biodiesel facility restart. The current technical setup extends this outlook by highlighting that traders should monitor the $221.41 resistance, as a breakout above this level would be the next indicator of sustained upside for CVX shares.

Source of Data: CVX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.